Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studies.
about
MAPK pathway activation in pilocytic astrocytomaWill kinase inhibitors make it as glioblastoma drugs?Contemporary murine models in preclinical astrocytoma drug developmentEpendymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models.Lentiviral-induced high-grade gliomas in rats: the effects of PDGFB, HRAS-G12V, AKT, and IDH1-R132H.Induction of histiocytic sarcoma in mouse skeletal muscle.Fusion of intestinal epithelial cells with bone marrow derived cells is dispensable for tissue homeostasis.Review: insights gained from modelling high-grade glioma in the mouse.Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear CellsGlioma: experimental models and reality.Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.Animal models for glioma drug discovery.Modeling and predicting clinical efficacy for drugs targeting the tumor milieu.Novel approaches to glioma drug design and drug screening.Nitroxoline induces apoptosis and slows glioma growth in vivo.Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.Modeling phenotypes of malignant gliomas.Survival and Proliferation of Neural Progenitor-Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism.Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration.Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2.Next-Generation Modeling of Human Cancers
P2860
Q27006028-0BD98180-AE7B-4286-BAA0-0BE8241DF712Q27012684-7EE4E616-0D23-4809-A941-743AEA0EE700Q27026937-22F6CE5F-0861-47E4-84D0-CF81508159B8Q33894470-DA62FA03-E32C-45D7-9194-AAD3AECE565AQ34000761-1B5293ED-AF80-4712-97DD-9E5EF346E6C0Q34406138-0FD9480E-C309-4CB1-B09D-BD853DB639D5Q35757793-C116CF44-9A25-4A75-A2DE-5D842282458BQ35854724-D8CBC112-539A-4211-8191-5BAC39B1AFA1Q36408364-A7FD214C-CFAA-4618-87F7-D25CFB4F4662Q37596796-994D5D17-1DE6-4B66-9A14-6F39FF0B8EF6Q37780775-ABB83ED1-9BF2-4E31-AD1C-8FCA8229D925Q38014575-A495CAF6-8EE1-4048-9452-B69B7F64F0E3Q38025261-60ED226A-8F98-4099-B10F-BB95BC55BF98Q38112184-86CE4F47-E14D-4AC4-98C9-547708C40A01Q38970495-29B23536-A2B0-4814-BA28-3AD8520A06E6Q48126015-7CA529C5-6917-481D-8442-32C08ECE5E84Q48159135-FFCA9B06-DB87-4C9E-9B1A-3F1BA75598B2Q50491825-D82BCF55-8524-480B-85A6-9E7FF1BD0D5CQ53265222-CCEA5936-02B3-4496-9111-93C6A2CA41B8Q55500980-FCBB6FA9-D059-40D8-9A85-78AE2A0E7D41Q58576103-94E003D3-7554-4508-B4D4-3841DF70DF8F
P2860
Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studies.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Rapid and robust transgenic hi ...... therapy intervention studies.
@en
Rapid and robust transgenic hi ...... therapy intervention studies.
@nl
type
label
Rapid and robust transgenic hi ...... therapy intervention studies.
@en
Rapid and robust transgenic hi ...... therapy intervention studies.
@nl
prefLabel
Rapid and robust transgenic hi ...... therapy intervention studies.
@en
Rapid and robust transgenic hi ...... therapy intervention studies.
@nl
P2093
P1476
Rapid and robust transgenic hi ...... therapy intervention studies.
@en
P2093
Anton J M Berns
Bob C Hamans
Danielle Hulsman
Hilda I de Vries
John Zevenhoven
Jos H Beijnen
Maarten van Lohuizen
Nienke A de Vries
Olaf van Tellingen
Sophia W Bruggeman
P304
P356
10.1158/1078-0432.CCR-09-3414
P407
P577
2010-05-14T00:00:00Z